Valuation (53%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -81.07 | 21.87 |
| PEG Ratio (TTM) | -8.27 | 1.23 |
| P/S Ratio (TTM) | 3.11 | 7.19 |
| P/B Ratio (TTM) | 2.96 | 6.80 |
| P/FCF Ratio (TTM) | 14.01 | 31.63 |
| Price to 5YR AVG Earnings Ratio | 43.53 | 35.28 |
| Price to 5YR AVG FCF Ratio | 12.39 | 41.48 |
Profitability (10%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -1.20% | 20.01% |
| ROE (TTM) | -3.87% | 28.62% |
| Net Profit Margin (TTM) | -3.84% | 12.87% |
| ROIC 5YR AVG | 11.96% | 24.57% |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -158.59% | -21.58% | 793.63% |
| Revenue | 0.57% | 32.90% | 17.79% |
| Net Income | -160.97% | -21.01% | 826.44% |
| Cash Flow | 28.77% | 51.31% | 28.98% |
Health (54%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 9.35 | 2.34 |
| Quick Ratio (TTM) | 9.35 | 2.34 |
| D/E Ratio (TTM) | 1.75 | 0.03 |
| Interest Coverage (TTM) | -2.91 | 229.08 |
| Piotroski F-Score | 7 | 7 |
| Altman Z-Score | 1.93 | 12.54 |
| LTL to 5YR AVG FCF | 7.27 | 0.54 |
| Shares Outstanding Growth 5YR AVG | 0.46% | -1.43% |